Evidence map›Paper›PMID 35865541›Full record

ArticleFrontiers in immunology2022

Inhibition of Notch Signaling Stimulates Osteoclastogenesis From the Common Trilineage Progenitor Under Inflammatory Conditions.

Maša Filipović, Darja Flegar, Alan Šućur, Dino Šisl, Inga Kavazović, Mariastefania Antica, Tomislav Kelava, Nataša Kovačić, Danka Grčević

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Maša FilipovićDepartment of Physiology and Immunology, University of Zagreb School of Medicine, Zagreb, Croatia.
Darja FlegarDepartment of Physiology and Immunology, University of Zagreb School of Medicine, Zagreb, Croatia.
Alan ŠućurDepartment of Physiology and Immunology, University of Zagreb School of Medicine, Zagreb, Croatia.
Dino ŠislDepartment of Physiology and Immunology, University of Zagreb School of Medicine, Zagreb, Croatia.
Inga KavazovićDepartment of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Mariastefania AnticaDivision of Molecular Biology, Ruđer Bošković Institute, Zagreb, Croatia.
Tomislav KelavaDepartment of Physiology and Immunology, University of Zagreb School of Medicine, Zagreb, Croatia.
Nataša KovačićLaboratory for Molecular Immunology, Croatian Institute for Brain Research, University of Zagreb School of Medicine, Zagreb, Croatia.
Danka GrčevićDepartment of Physiology and Immunology, University of Zagreb School of Medicine, Zagreb, Croatia.
University of Zagreb · HRRudjer Boskovic Institute · HRUniversity of Rijeka · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoclasts, macrophages and dendritic cells (DCs) can be derived from a common trilineage myeloid progenitor of hematopoietic origin. Progenitor commitment is susceptible to regulation through Notch signaling. Our aim was to determine the effects of Notch modulation on trilineage progenitor commitment and functional properties of differentiated cells under inflammatory conditions. We used the conditional inducible CX3CR1CreERT2 mouse strain to achieve overexpression of the Notch 1 intracellular domain (NICD1) or to inhibit Notch signaling

Indexed as

Macrophage Colony-Stimulating FactorOsteogenesisReceptors, NotchAnimalsEscherichia coliInflammationLipopolysaccharidesMacrophagesMiceOsteoclastsSignal TransductionLipopolysaccharidesMacrophage Colony-Stimulating FactorReceptors, Notchdendritic cellinflammationmacrophagemyeloid progenitorNotchosteoclast

Identifiers

PMID35865541
PMCPMC9294223
OpenAlexW4283820786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.